Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 212

1.

Impact of meconium consistency on infant resuscitation and respiratory outcomes: a retrospective-cohort study and systematic review.

Kitsommart R, Thammawong N, Sommai K, Yangnoy J, Bowornkitiwong W, Paes B.

J Matern Fetal Neonatal Med. 2020 Jan 3:1-7. doi: 10.1080/14767058.2019.1706476. [Epub ahead of print]

PMID:
31900012
2.

Hip external rotation stiffness and midfoot passive mechanical resistance are associated with lower limb movement in the frontal and transverse planes during gait.

Cardoso TB, Ocarino JM, Fajardo CC, Paes BDC, Souza TR, Fonseca ST, Resende RA.

Gait Posture. 2020 Feb;76:305-310. doi: 10.1016/j.gaitpost.2019.12.030. Epub 2019 Dec 24.

PMID:
31887703
3.

Inferior vena cava syndrome in neonates: An evidence-based systematic review of the literature.

Tieu P, Paes B, Ahmed A, Matino D, Chan A, Bhatt M.

Pediatr Blood Cancer. 2020 Apr;67(4):e28114. doi: 10.1002/pbc.28114. Epub 2019 Dec 26. Review.

PMID:
31876366
4.

Accuracy of Using a Point-of-Care Glucometer for Cerebrospinal Fluid Glucose Screening in Resource-Limited Countries.

Kitsommart R, Wongsinin T, Swasee U, Paes B.

Hosp Pediatr. 2019 Sep;9(9):665-672. doi: 10.1542/hpeds.2019-0003.

PMID:
31434686
5.

Respiratory illness and respiratory syncytial virus hospitalization in infants with a tracheostomy following prophylaxis with palivizumab.

Paes B, Saleem M, Kim D, Lanctôt KL, Mitchell I.

Eur J Clin Microbiol Infect Dis. 2019 Aug;38(8):1561-1568. doi: 10.1007/s10096-019-03588-x. Epub 2019 May 22.

PMID:
31119575
6.

The clinical measure of forefoot-shank alignment partially reflects mechanical properties of the midfoot joint complex.

Paes BDDC, Resende RA, Gomes RB, Gontijo BA, Magalhães FA, Ocarino JM, Fonseca ST, Souza TR.

Musculoskelet Sci Pract. 2019 Jul;42:98-103. doi: 10.1016/j.msksp.2019.04.016. Epub 2019 May 12.

PMID:
31102822
7.

Expert consensus on palivizumab use for respiratory syncytial virus in developed countries.

Luna MS, Manzoni P, Paes B, Baraldi E, Cossey V, Kugelman A, Chawla R, Dotta A, Rodríguez Fernández R, Resch B, Carbonell-Estrany X.

Paediatr Respir Rev. 2020 Feb;33:35-44. doi: 10.1016/j.prrv.2018.12.001. Epub 2018 Dec 18. Review.

PMID:
31060948
8.

Respiratory Syncytial Virus Prophylaxis in Neurologic and Muscular Disorders in the Canadian Respiratory Syncytial Virus Evaluation Study of Palivizumab.

Wang DY, Saleem M, Paes BA, Mitchell I, Li A, Lanctôt KL; CARESS Investigators.

Pediatr Infect Dis J. 2019 Aug;38(8):775-780. doi: 10.1097/INF.0000000000002297.

PMID:
30985509
9.

Foot pronation during walking is associated to the mechanical resistance of the midfoot joint complex.

Gomes RBO, Souza TR, Paes BDC, Magalhães FA, Gontijo BA, Fonseca ST, Ocarino JM, Resende RA.

Gait Posture. 2019 May;70:20-23. doi: 10.1016/j.gaitpost.2019.01.027. Epub 2019 Feb 10.

PMID:
30780086
10.

Respiratory syncytial virus prophylaxis for children with chronic lung disease: have we got the criteria right?

Paes B, Carbonell-Estrany X.

Expert Rev Anti Infect Ther. 2019 Apr;17(4):211-222. doi: 10.1080/14787210.2019.1581062. Epub 2019 Feb 26.

PMID:
30739513
11.

Respiratory syncytial virus prophylaxis in infants with congenital airway anomalies compared to standard indications and complex medical disorders.

Paes B, Kim D, Saleem M, Wong S, Mitchell I, Lanctot KL; and the CARESS investigators.

Eur J Pediatr. 2019 Mar;178(3):377-385. doi: 10.1007/s00431-018-03308-1. Epub 2019 Jan 4.

PMID:
30610419
12.

Palivizumab for children with Down syndrome: is the time right for a universal recommendation?

Paes B, Mitra S.

Arch Dis Child. 2019 Aug;104(8):719-721. doi: 10.1136/archdischild-2018-316408. Epub 2018 Dec 27. No abstract available.

PMID:
30591428
13.

Outcomes following neonatal portal vein thrombosis: A descriptive, single-center study and review of anticoagulant therapy.

Bhatt MD, Patel V, Butt ML, Chan AKC, Paes B; Thrombosis and Hemostasis in Newborns (THiN) Group.

Pediatr Blood Cancer. 2019 Apr;66(4):e27572. doi: 10.1002/pbc.27572. Epub 2018 Dec 5.

PMID:
30520242
14.
15.

Respiratory syncytial virus (RSV) infection in children with medical complexity.

Lim A, Butt ML, Dix J, Elliott L, Paes B.

Eur J Clin Microbiol Infect Dis. 2019 Jan;38(1):171-176. doi: 10.1007/s10096-018-3409-1. Epub 2018 Oct 29.

PMID:
30374685
16.

Respiratory syncytial virus hospitalization and incurred morbidities the season after prophylaxis.

Butt ML, Elliott L, Paes BA.

Paediatr Child Health. 2018 Nov;23(7):441-446. doi: 10.1093/pch/pxy046. Epub 2018 Apr 14.

17.

Hospitalization for Respiratory Syncytial Virus in Children with Down Syndrome Less than 2 Years of Age: A Systematic Review and Meta-Analysis.

Mitra S, El Azrak M, McCord H, Paes BA.

J Pediatr. 2018 Dec;203:92-100.e3. doi: 10.1016/j.jpeds.2018.08.006. Epub 2018 Sep 25.

PMID:
30266507
18.

Predictive factors for intensive birth resuscitation in a developing-country: a 5-year, single-center study.

Yangthara B, Horrasith S, Paes B, Kitsommart R.

J Matern Fetal Neonatal Med. 2020 Feb;33(4):570-576. doi: 10.1080/14767058.2018.1497602. Epub 2018 Sep 10.

PMID:
29973079
19.

Pediatric superior vena cava syndrome: An evidence-based systematic review of the literature.

Nossair F, Schoettler P, Starr J, Chan AKC, Kirov I, Paes B, Mahajerin A.

Pediatr Blood Cancer. 2018 Sep;65(9):e27225. doi: 10.1002/pbc.27225. Epub 2018 May 21. Review.

PMID:
29781569
20.

Respiratory syncytial virus prophylaxis in cystic fibrosis: the Canadian registry of palivizumab data (2005-2016).

Mitchell I, Wong SK, Paes B, Ruff M, Bjornson C, Li A, Lanctôt KL; CARESS investigators.

Eur J Clin Microbiol Infect Dis. 2018 Jul;37(7):1345-1352. doi: 10.1007/s10096-018-3256-0. Epub 2018 May 4.

PMID:
29728782
21.

Conservative management of neonatal cerebral sinovenous thrombosis with coexisting thrombophilia.

Khatri V, Chan AKC, Stein N, Paes B, Bhatt M.

Blood Coagul Fibrinolysis. 2018 Jun;29(4):399-403. doi: 10.1097/MBC.0000000000000731.

PMID:
29708897
22.

Respiratory Syncytial Virus in Otherwise Healthy Prematurely Born Infants: A Forgotten Majority.

Paes B.

Am J Perinatol. 2018 May;35(6):541-544. doi: 10.1055/s-0038-1637762. Epub 2018 Apr 25. Review.

PMID:
29694992
23.

Palivizumab prophylaxis for respiratory syncytial virus in infants with cystic fibrosis: is there a need?

Bjornson C, Chan P, Li A, Paes B, Lanctôt KL, Mitchell I.

Eur J Clin Microbiol Infect Dis. 2018 Jun;37(6):1113-1118. doi: 10.1007/s10096-018-3225-7. Epub 2018 Mar 19.

PMID:
29557081
24.

Past, Present and Future Approaches to the Prevention and Treatment of Respiratory Syncytial Virus Infection in Children.

Simões EAF, Bont L, Manzoni P, Fauroux B, Paes B, Figueras-Aloy J, Checchia PA, Carbonell-Estrany X.

Infect Dis Ther. 2018 Mar;7(1):87-120. doi: 10.1007/s40121-018-0188-z. Epub 2018 Feb 22. Review.

25.

Risk scoring tool to predict respiratory syncytial virus hospitalisation in premature infants.

Blanken MO, Paes B, Anderson EJ, Lanari M, Sheridan-Pereira M, Buchan S, Fullarton JR, Grubb E, Notario G, Rodgers-Gray BS, Carbonell-Estrany X.

Pediatr Pulmonol. 2018 May;53(5):605-612. doi: 10.1002/ppul.23960. Epub 2018 Feb 6.

26.

Positive end-expiratory pressure during resuscitation at birth in very-low birth weight infants: A randomized-controlled pilot trial.

Kitsommart R, Nakornchai K, Yangthara B, Jiraprasertwong R, Paes B.

Pediatr Neonatol. 2018 Oct;59(5):448-454. doi: 10.1016/j.pedneo.2017.12.002. Epub 2017 Dec 9.

27.

Adherence and outcomes: a systematic review of palivizumab utilization.

Wong SK, Li A, Lanctôt KL, Paes B.

Expert Rev Respir Med. 2018 Jan;12(1):27-42. doi: 10.1080/17476348.2018.1401926. Epub 2017 Nov 13. Review.

PMID:
29130355
28.

Global respiratory syncytial virus-associated mortality in young children (RSV GOLD): a retrospective case series.

Scheltema NM, Gentile A, Lucion F, Nokes DJ, Munywoki PK, Madhi SA, Groome MJ, Cohen C, Moyes J, Thorburn K, Thamthitiwat S, Oshitani H, Lupisan SP, Gordon A, Sánchez JF, O'Brien KL; PERCH Study Group, Gessner BD, Sutanto A, Mejias A, Ramilo O, Khuri-Bulos N, Halasa N, de-Paris F, Pires MR, Spaeder MC, Paes BA, Simões EAF, Leung TF, da Costa Oliveira MT, de Freitas Lázaro Emediato CC, Bassat Q, Butt W, Chi H, Aamir UB, Ali A, Lucero MG, Fasce RA, Lopez O, Rath BA, Polack FP, Papenburg J, Roglić S, Ito H, Goka EA, Grobbee DE, Nair H, Bont LJ.

Lancet Glob Health. 2017 Oct;5(10):e984-e991. doi: 10.1016/S2214-109X(17)30344-3. Erratum in: Lancet Glob Health. 2017 Dec;5(12 ):e1190.

29.

Induced Pluripotent Stem Cell for the Study and Treatment of Sickle Cell Anemia.

Junqueira Reis LC, Picanço-Castro V, Paes BCMF, Pereira OA, Gerdes Gyuricza I, de Araújo FT, Morato-Marques M, Moreira LF, Costa EBO, Dos Santos TPM, Covas DT, Pereira Carramaschi LDV, Russo EMS.

Stem Cells Int. 2017;2017:7492914. doi: 10.1155/2017/7492914. Epub 2017 Jul 26.

30.

Defining the Incidence and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Children with Chronic Diseases.

Manzoni P, Figueras-Aloy J, Simões EAF, Checchia PA, Fauroux B, Bont L, Paes B, Carbonell-Estrany X.

Infect Dis Ther. 2017 Sep;6(3):383-411. doi: 10.1007/s40121-017-0160-3. Epub 2017 Jun 26. Review.

31.

Comparing First- and Second-year Palivizumab Prophylaxis in Patients With Hemodynamically Significant Congenital Heart Disease in the CARESS Database (2005-2015).

Li A, Wang DY, Lanctôt KL, Mitchell I, Paes BA; CARESS Investigators.

Pediatr Infect Dis J. 2017 May;36(5):445-450. doi: 10.1097/INF.0000000000001357.

PMID:
28403044
32.

The Burden and Long-term Respiratory Morbidity Associated with Respiratory Syncytial Virus Infection in Early Childhood.

Fauroux B, Simões EAF, Checchia PA, Paes B, Figueras-Aloy J, Manzoni P, Bont L, Carbonell-Estrany X.

Infect Dis Ther. 2017 Jun;6(2):173-197. doi: 10.1007/s40121-017-0151-4. Epub 2017 Mar 29. Review.

33.

Myocardial Infarction in Neonates: A Review of an Entity with Significant Morbidity and Mortality.

Papneja K, Chan AK, Mondal TK, Paes B.

Pediatr Cardiol. 2017 Mar;38(3):427-441. doi: 10.1007/s00246-016-1556-7. Epub 2017 Feb 25. Review.

PMID:
28238152
34.

Re: "Completed Weeks of Gestation and Risk of Respiratory Syncytial Virus in Late Preterm Infants".

Sheridan-Pereira M, Paes B.

Pediatr Infect Dis J. 2017 Dec;36(12):1227-1228. doi: 10.1097/INF.0000000000001577. No abstract available.

PMID:
28198790
35.

First versus second year respiratory syncytial virus prophylaxis in chronic lung disease (2005-2015).

Wang DY, Li A, Paes B, Mitchell I, Lanctôt KL; CARESS Investigators.

Eur J Pediatr. 2017 Mar;176(3):413-422. doi: 10.1007/s00431-017-2849-4. Epub 2017 Jan 20.

36.

Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Infants with Congenital Heart Disease.

Checchia PA, Paes B, Bont L, Manzoni P, Simões EA, Fauroux B, Figueras-Aloy J, Carbonell-Estrany X.

Infect Dis Ther. 2017 Mar;6(1):37-56. doi: 10.1007/s40121-016-0142-x. Epub 2017 Jan 9. Review.

37.

Ten years of iPSC: clinical potential and advances in vitro hematopoietic differentiation.

Paes BCMF, Moço PD, Pereira CG, Porto GS, de Sousa Russo EM, Reis LCJ, Covas DT, Picanço-Castro V.

Cell Biol Toxicol. 2017 Jun;33(3):233-250. doi: 10.1007/s10565-016-9377-2. Epub 2016 Dec 30. Review.

PMID:
28039590
38.

Hospital admissions for lower respiratory tract infections among infants in the Canadian Arctic: a cohort study.

Banerji A, Panzov V, Young M, Robinson J, Lee B, Moraes T, Mamdani M, Giles BL, Jiang D, Bisson D, Dennis M, Morel J, Hall J, Hui C, Paes B, Mahony JB.

CMAJ Open. 2016 Oct 17;4(4):E615-E622. doi: 10.9778/cmajo.20150051. eCollection 2016 Oct-Dec.

39.

Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Infants with Chronic Lung Disease.

Paes B, Fauroux B, Figueras-Aloy J, Bont L, Checchia PA, Simões EA, Manzoni P, Carbonell-Estrany X.

Infect Dis Ther. 2016 Dec;5(4):453-471. Epub 2016 Nov 18. Review.

40.

Impact of a dedicated neonatal stabilization room and process changes on stabilization time.

Shivananda S, Gupta S, Thomas S, Babb L, Meyer CL, Symington A, Paes B, Suresh GK.

J Perinatol. 2017 Feb;37(2):162-167. doi: 10.1038/jp.2016.205. Epub 2016 Nov 10.

PMID:
27831550
41.

Palivizumab Adherence and Outcomes in Canadian Aboriginal Children.

Hui C, Paes B, Papenburg J, Mitchell I, Li A, Lanctôt KL; CARESS Investigators.

Pediatr Infect Dis J. 2016 Nov;35(11):1187-1193.

PMID:
27331856
42.

Burden of Severe Respiratory Syncytial Virus Disease Among 33-35 Weeks' Gestational Age Infants Born During Multiple Respiratory Syncytial Virus Seasons.

Anderson EJ, Carbonell-Estrany X, Blanken M, Lanari M, Sheridan-Pereira M, Rodgers-Gray B, Fullarton J, Rouffiac E, Vo P, Notario G, Campbell F, Paes B.

Pediatr Infect Dis J. 2017 Feb;36(2):160-167. doi: 10.1097/INF.0000000000001377.

43.

Outcomes of Infants Receiving Palivizumab Prophylaxis for Respiratory Syncytial Virus in Canada and Italy: An International, Prospective Cohort Study.

Manzoni P, Paes B, Lanctôt KL, Dall'Agnola A, Mitchell I, Calabrese S, Maule M, Girardi E, Harimoto T, Li A.

Pediatr Infect Dis J. 2017 Jan;36(1):2-8.

PMID:
27649365
44.

Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Preterm Infants Without Chronic Lung Disease or Congenital Heart Disease.

Figueras-Aloy J, Manzoni P, Paes B, Simões EA, Bont L, Checchia PA, Fauroux B, Carbonell-Estrany X.

Infect Dis Ther. 2016 Dec;5(4):417-452. Epub 2016 Sep 14. Review.

45.

Defining the Epidemiology and Burden of Severe Respiratory Syncytial Virus Infection Among Infants and Children in Western Countries.

Bont L, Checchia PA, Fauroux B, Figueras-Aloy J, Manzoni P, Paes B, Simões EA, Carbonell-Estrany X.

Infect Dis Ther. 2016 Sep;5(3):271-98. doi: 10.1007/s40121-016-0123-0. Epub 2016 Aug 1. Review.

46.

Neonatal central venous catheter thrombosis: diagnosis, management, and outcome.

Park CK, Paes BA, Nagel K, Chan AK, Murthy P; Thrombosis, Hemostasis in Newborns (THiN) Group.

Blood Coagul Fibrinolysis. 2016 Jul 29. [Epub ahead of print]

PMID:
27479452
47.

The Hydroalcoholic Extract of Leaves of Mandevilla moricandiana Induces NO-Mediated Vascular Relaxation.

Ferreira LL, Gomes MV, Paes BM, do Carmo PL, Konno TU, Esteves FA, Lopes NP, Tomaz JC, Leal IC, Guimarães DO, Muzitano MF, Raimundo JM.

Planta Med. 2017 Jan;83(1-02):63-69. doi: 10.1055/s-0042-108203. Epub 2016 Jun 10.

PMID:
27286329
48.

Patent foramen ovale and stroke in childhood: A systematic review of the literature.

Khan R, Chan AK, Mondal TK, Paes BA; Thrombosis and Hemostasis in Newborns (THIN) Group.

Eur J Paediatr Neurol. 2016 Jul;20(4):500-11. doi: 10.1016/j.ejpn.2016.04.012. Epub 2016 Apr 28. Review.

PMID:
27169856
49.

The association of platelets with failed patent ductus arteriosus closure after a primary course of indomethacin or ibuprofen: a systematic review and meta-analysis.

Mitra S, Chan AK, Paes BA; Thrombosis and Hemostasis in Newborns (THIN) Group.

J Matern Fetal Neonatal Med. 2017 Jan;30(2):127-133. Epub 2016 Apr 14. Review.

PMID:
26955892
50.

Adherence to Palivizumab for Respiratory Syncytial Virus Prevention in the Canadian Registry of Palivizumab.

Chan P, Li A, Paes B, Abraha H, Mitchell I, Lanctôt KL; CARESS investigators.

Pediatr Infect Dis J. 2015 Dec;34(12):e290-7. doi: 10.1097/INF.0000000000000922.

PMID:
26780032

Supplemental Content

Support Center